LOS ANGELES — Victor Wembanyama is doing something wrong. The 7-foot-4 unicorn, still in the early stages of rewriting how basketball is played, just made a move few in the world can. But it’s the ...
Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new research. The nationwide TORPEdO trial funded by ...
Abstract: Whether in analog or digital phased arrays, the predominant factor contributing to beam pointing deviation, particularly in extensive angle scanning scenarios, is the anisotropy of antenna ...
EUFAULA, Ala. (WRBL) — It’s Election Day in Eufaula. And the East Alabama city is just hours away from deciding if it is going to stick with a 13-year incumbent mayor – or make a change. This ...
JERUSALEM, Sept 17 (Reuters) - A low-cost, high-power laser-based system aimed at destroying incoming missiles has successfully completed testing and will be ready for operational use by the military ...
Thursday marks the 24th anniversary of one of the darkest days in American history. The Sept. 11, 2001, attacks in New York City, Washington, DC, and Shanksville, Pennsylvania, killed nearly 3,000 ...
Findings showed Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines. Topline data were announced from a phase 3 trial evaluating Merck’s 21-valent ...
Dinosaur eggs from China found to be around 86 million years old, according to ‘atomic clock’ dating
A clutch of 28 dinosaur eggs found in the Qinglongshan fossil reserve in central China is about 86 million years old, according to scientists who used an “atomic clock” method to date the samples.
Delegates eye mockups of Rafael's Iron Beam laser cannons at the DSEI trade show in London on Sept. 9, 2025. (Sebastian Sprenger/staff) JERUSALEM — Rafael Advanced Defense Systems brought replicas of ...
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...
A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), demonstrated manageable safety and early signs of anti-tumor activity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback